Tradestie Institutional Equity Comparison Engine

RCUS vs NUVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NUVB Overall Edge

NUVB Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuvation Bio Inc. (NUVB) driven by superior Growth & Margin, Momentum & Technical while RCUS counters with relative strength in Options & Structure. Fundamentally, RCUS trades at N/M Forward P/E with -475.0% operating margin (-65.4% YoY revenue) versus NUVB at N/M Forward P/E and -61.2% operating margin (+242.6% YoY). In options structure, RCUS sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RCUS N/M vs NUVB N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -475.0% vs -61.2% ยท YoY -65.4% vs +242.6%
Momentum & Technical Winner NUVB
1Y -22.8% vs -46.9% ยท 52W Pos 0% vs 2%
Options & Structure Winner RCUS
BREAKDOWN (11th %ile IV) vs BREAKDOWN (26th %ile IV)
RCUS NYSE
Arcus Biosciences, Inc.
Pharmaceutical Preparations
$15.62
-1.01% 1D
Market Cap $2.3B
1M Return -19.32%
1Y Return -22.75%
Forward P/E N/M
Unified AI Score
48.9 / 100 HOLD
Tech 44.0 Fund 56.0 Flow 70.0 Mom 55.0
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RCUS -22.75% NUVB -46.85% Spread: +24.1 pp (RCUS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RCUS Revenue NUVB Revenue RCUS Op. Margin NUVB Op. Margin Margin Edge
FY2018 $10M N/A -656.8% N/A RCUS
FY2019 $10M N/A -591.4% N/A RCUS
FY2020 $80M N/A -159.0% N/A RCUS
FY2021 $380M N/A 14.1% N/A RCUS
FY2022 $40M N/A -736.8% N/A RCUS
FY2023 $40M N/A -918.9% N/A RCUS
FY2024 $50M $10M -647.1% -7527.3% RCUS
FY2025 $30M $60M -1169.7% -338.7% NUVB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RCUS (3) vs NUVB (5)
Institutional Metric RCUS NUVB Criterion Row Winner
Market Capitalization Scale $2.3B $1.3B Larger Scale RCUS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -65.4% +242.6% Higher Growth NUVB
Operating Margin (TTM) Profitability -475.0% -61.2% Higher Margin NUVB
Net Profit Margin Profitability 0.0% -67.4% Higher Margin RCUS
Return on Equity (ROE) Capital Efficiency -114.1% -49.1% Higher ROE NUVB
52-Week Range Position Momentum 0% ($16โ€“$32) 2% ($4โ€“$10) Stronger Trend NUVB
Beta / 30D Volatility Risk Regime 1.39ฮฒ ยท 54% Vol 1.52ฮฒ ยท 55% Vol Lower Realized Risk RCUS
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 61.0 / 100 (BUY) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RCUS vs NUVB Buy Guide
RCUS BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live RCUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RCUS nor NUVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.